Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05356611

Engage for Late-Life Depression and Comorbid Executive Dysfunction

Engage: A Treatment for Late-Life Depression and Comorbid Executive/Cognitive Dysfunction

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University of Nevada, Las Vegas · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

Although there are an increasing number of mental health treatment adaptations for older adults, there are still a number of factors to consider when making these adaptations. Cognitive decline is one such factor that places significant burden on older adults and can interfere with traditional mental health therapies. Engage is a behavioral treatment approach that has shown to be effective in treating late life depression. The investigators are testing the feasibility of Engage as a treatment method for late life depression in older adults with cognitive decline. The objective is to corroborate Engage as an alternative late life depression treatment method for a sub-population of older adults with cognitive decline. Cognitive decline poses a unique mental health treatment barrier that is often over looked in younger populations. With a relatively higher prevalence of cognitive decline in older adulthood, it is imperative that a feasible mental health treatment program that can be effective in the presence of cognitive decline.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEngageEngage is a 9-week, behavioral-based, psychotherapy treatment protocol for late-life depression.

Timeline

Start date
2023-09-24
Primary completion
2024-12-01
Completion
2025-05-01
First posted
2022-05-02
Last updated
2024-08-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05356611. Inclusion in this directory is not an endorsement.